Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 638-809-1 | 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one | 146939-27-7 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| STOT RE 2 | H373 (other:Damage to...) | H373 |
GHS08 Wng |
38 | View details | ||||||
| STOT RE 2 | H373 (Damage to organ...) | H373 | |||||||||
| STOT RE 2 | H373 (Central Nervous...) | H373 (Central Nervous...) |
GHS08 Wng |
State/Form
|
29 | View details | |||||
| STOT SE 3 | H336 (other:Affected ...) | H336 |
GHS07 Wng |
1 | View details | ||||||
| STOT SE 3 | H336 (Affected organs) | H336 | |||||||||
Number of Aggregated Notifications: 3